No connection

Search Results

Corporate Score 25 Neutral

Matinas BioPharma receives notice from NYSE

Apr 03, 2026 21:20 UTC
MATN
Short term

Matinas BioPharma receives notice from NYSE.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI
Markets
Profile